Cefwin-TZ 281.25 mg Injection

Products Enquiry

    Enquiry for

    Enquiry for

    Cefwin-TZ 281.25 mg Injection
    Cefwin-TZ 281.25 mg Injection - Image 2
    Cefwin-TZ 281.25 mg Injection - Image 3
    Cefwin-TZ 281.25 mg Injection - Image 4
    Cefwin-TZ 281.25 mg Injection - Image 5

    Cefwin-TZ 281.25 mg Injection

    Cefepime 250 mg & Tazobactam 31.25 mg
    Antibiotic | Anti-Infective
    20 ml vial with 10 ml WFI & insert in mono carton
    • Bacteraemia & Septicaemia | Febrile Neutropenia
    • Surgical Prophylaxis | Intra-abdominal Infections
    • Bacterial Meningitis | Complicated UTI’s & SSTI’s
    • CAP & Nosocomial Pneumonia
    Susceptible infections Mild to moderate: 1-2 g/day in 2 divided doses. Severe: Up to 4 g/day in 2 divided doses. Empirical therapy for febrile neutropenia Up to 6 g/day in 3 divided doses
    Product Enquiry
    Categories: , , , , ,

    Product Information

    Product Description :

    Cefwin-TZ 281.25 mg Injection is prescribed to treat various types of bacterial infections. It fights against the infection by preventing the growth of microorganisms.

    Benefits :

    Treatment of Bacterial Infections

    Direction For Use :

    • Cefwin-TZ 281.25 mg Injection is generally given under the supervision of a doctor or a nurse and should not be self-administered.
    • The doctor will decide the dose and duration of the treatment.

    Mechanism of Action :

    Cefwin-TZ 281.25 mg Injection is a combination of two medicines: Cefepime and Tazobactum. Cefepime is an antibiotic. It works by preventing the formation of the bacterial protective covering which is essential for the survival of bacteria in the human body. Tazobactum is a beta-lactamase inhibitor which blocks the action of enzymes produced by bacteria to inactivate cefepime. Addition of Tazobactum reduces resistance and enhances the activity of Cefepime against bacteria.

    Also Available :

    Related products